1. Home
  2. VREX vs PRLD Comparison

VREX vs PRLD Comparison

Compare VREX & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.55

Market Cap

447.2M

Sector

Technology

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.23

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
PRLD
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.2M
391.1M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
VREX
PRLD
Price
$10.55
$4.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$16.67
$5.67
AVG Volume (30 Days)
473.8K
560.0K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
$811,000,000.00
$12,140,000.00
Revenue This Year
$5.35
$320.10
Revenue Next Year
$3.88
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$6.76
$0.75
52 Week High
$14.57
$5.69

Technical Indicators

Market Signals
Indicator
VREX
PRLD
Relative Strength Index (RSI) 49.67 43.30
Support Level $10.18 $3.92
Resistance Level $10.87 $5.52
Average True Range (ATR) 0.58 0.45
MACD 0.01 -0.09
Stochastic Oscillator 61.10 12.20

Price Performance

Historical Comparison
VREX
PRLD

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: